Law, Susan W.
Levine, Steven R.
Article History
First Online: 16 December 2015
Competing interests
: S.R.L. serves on the scientific advisory and steering committee of and as a site investigator for PRISMS, a Genentech-sponsored, phase IIIb, randomized, placebo-controlled clinical trial of intravenous tissue plasminogen activator (IV tPA) for minor stroke. He has also received an investigator-initiated grant from Genentech to study physician decision making in the use of tPA for minor and rapidly improving stroke. He has provided expert testimony for both patients and physicians concerning IV tPA. S.W.L. declares no competing interests.